Quantitative ultrasound monitoring of breast tumor response to chemotherapy by analysis of frequency-dependent attenuation and backscattered power

H. Tadayyon; Lakshmanan Sannachi; G. J. Czarnota

doi:10.1117/12.2043075

Translator Disclaimer

20 March 2014 Quantitative ultrasound monitoring of breast tumor response to chemotherapy by analysis of frequency-dependent attenuation and backscattered power

H. Tadayyon, Lakshmanan Sannachi, G. J. Czarnota

Author Affiliations +

Proceedings Volume 9040, Medical Imaging 2014: Ultrasonic Imaging and Tomography; 904009 (2014) https://doi.org/10.1117/12.2043075
Event: SPIE Medical Imaging, 2014, San Diego, California, United States

Abstract

Conventional assessment of tumor response to anti-cancer therapy is based on measurements of tumor size (RECIST criteria). However, these measurements are typically a late indicator of tumor response (detectable after several weeks to a few months). There is currently no method to assess tumor response early in the course of therapy. In this study, quantitative ultrasound (QUS) methods were used to characterize the frequency-dependent attenuation and backscatter properties of treatment responding and non-responding tumors in breast cancer patients receiving neoadjuvant chemotherapy. In addition, we assessed the effects of attenuation correction of the power spectrum on the ability to differentiate between responding and non-responding tumors during the course of treatment.

Citation Download Citation

H. Tadayyon, Lakshmanan Sannachi, and G. J. Czarnota "Quantitative ultrasound monitoring of breast tumor response to chemotherapy by analysis of frequency-dependent attenuation and backscattered power", Proc. SPIE 9040, Medical Imaging 2014: Ultrasonic Imaging and Tomography, 904009 (20 March 2014); https://doi.org/10.1117/12.2043075

ACCESS THE FULL ARTICLE